Article content

BlackBerry Ltd. and NantHealth, a U.S. health care-focused technology company, have launched a platform which allows healthcare professionals to access cancer patients’ detailed genome data — and make tailored treatment decisions for that individual’s tumour — from a Passport smartphone.

The launch of the NantOmics Cancer Genome Browser comes after the Waterloo, Ont.-based smartphone pioneer earlier this year took a minority stake in NantHealth (whose billionaire founder and chief executive, Dr. Patrick Soon-Shiong, is the richest physician in the world, according to Forbes, and part-owner of the L.A. Lakers basketball team).

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or BlackBerry Ltd launches smartphone app with NantHealth for doctors to access cancer genome data Back to video

This push into medical technology fits with BlackBerry’s aim to leverage its encryption and security expertise in sectors like health care where data must be highly-regulated.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or

“BlackBerry’s partnership with NantHealth illustrates how the mobile security and collaboration technology we are known for can be reimagined to create revolutionary applications across a variety of industries,” said John Chen, executive chairman and chief executive of BlackBerry in a statement Monday.